These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28581996)

  • 21. Predictors of Prolonged In-Hospital Stay After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.
    Isik T; Ayhan E; Uluganyan M; Gunaydin ZY; Uyarel H
    Angiology; 2016 Sep; 67(8):756-61. PubMed ID: 26582944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A decade of improvement in the management of New Zealand ST-elevation myocardial infarction (STEMI) patients: results from the New Zealand Acute Coronary Syndrome (ACS) Audit Group national audits of 2002, 2007 and 2012.
    Elliott JM; Wang TK; Gamble GD; Williams MJ; Matsis P; Troughton R; Hamer A; Devlin G; Mann S; Richards M; French JK; White HD; Ellis CJ
    N Z Med J; 2017 Apr; 130(1453):17-28. PubMed ID: 28384143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic impact of prepercutaneous coronary intervention TIMI flow in patients with ST-segment and non-ST-segment elevation myocardial infarction: Results from the FAST-MI 2010 registry.
    Bailleul C; Aissaoui N; Cayla G; Dillinger JG; Jouve B; Schiele F; Ferrières J; Simon T; Danchin N; Puymirat E;
    Arch Cardiovasc Dis; 2018 Feb; 111(2):101-108. PubMed ID: 28939193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of multivessel coronary artery disease on reperfusion success in patients with ST-elevation myocardial infarction: A substudy of the AIDA STEMI trial.
    de Waha S; Eitel I; Desch S; Fuernau G; Pöss J; Schuler G; Thiele H
    Eur Heart J Acute Cardiovasc Care; 2017 Oct; 6(7):592-600. PubMed ID: 26691729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-Analysis of Randomized Trials on Remote Ischemic Conditioning During Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction.
    Elbadawi A; Ha LD; Abuzaid AS; Crimi G; Azzouz MS
    Am J Cardiol; 2017 Mar; 119(6):832-838. PubMed ID: 28065491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prehospital Evaluation, ED Management, Transfers, and Management of Inpatient STEMI.
    Govea A; Lipinksi J; Patel MP
    Interv Cardiol Clin; 2021 Jul; 10(3):293-306. PubMed ID: 34053616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute ST-elevation myocardial infarction in patients hospitalized for noncardiac conditions.
    Dai X; Bumgarner J; Spangler A; Meredith D; Smith SC; Stouffer GA
    J Am Heart Assoc; 2013 Apr; 2(2):e000004. PubMed ID: 23557748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between treatment delay and type of reperfusion therapy and mechanical complications of acute myocardial infarction.
    Magalhães P; Mateus P; Carvalho S; Leão S; Cordeiro F; Moreira JI;
    Eur Heart J Acute Cardiovasc Care; 2016 Sep; 5(5):468-74. PubMed ID: 26927002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meta-analysis of randomized controlled trials comparing percutaneous coronary intervention with aspiration thrombectomy Vs. Conventional percutaneous coronary intervention during ST-segment elevation myocardial infarction.
    Dominguez AC; Bittl JA; El-Hayek G; Contreras E; Tamis-Holland JE
    Catheter Cardiovasc Interv; 2016 Jun; 87(7):1203-10. PubMed ID: 26699698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Onset-to-device time of patients who arrive at off-hours: Importance of prehospital management and public awareness for patients with ST-segment elevation myocardial infarction.
    Mizuguchi Y; Shibutani H; Hashimoto S; Yamada T; Taniguchi N; Nakajima S; Hata T; Takahashi A
    Cardiovasc Ther; 2016 Dec; 34(6):475-481. PubMed ID: 27607197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Very Low Risk for In-hospital Adverse Outcome Such as ST-elevation or Non-ST-elevation Myocardial Infarction in Patients Undergoing Knee Surgery.
    Talle A; Hashemzadeh M; Movahed MR
    Crit Pathw Cardiol; 2022 Jun; 21(2):84-86. PubMed ID: 35234177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of introducing a regional 24/7 primary percutaneous coronary intervention service network on treatment outcomes in patients with ST segment elevation myocardial infarction.
    Januś B; Rakowski T; Dziewierz A; Fijorek K; Sokołowski A; Dudek D
    Kardiol Pol; 2015; 73(5):323-30. PubMed ID: 25428812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis.
    Niu X; Zhang J; Bai M; Peng Y; Sun S; Zhang Z
    BMC Cardiovasc Disord; 2018 Jan; 18(1):3. PubMed ID: 29320987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse outcomes in hospitalized patients who develop ST-elevation myocardial infarction.
    Richmond T; Holoshitz N; Haryani A; Purim-Shem-Tov Y; Sharma G; Schaer GL
    Crit Pathw Cardiol; 2014 Jun; 13(2):62-5. PubMed ID: 24827882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local Matrix Metalloproteinase 9 Level Determines Early Clinical Presentation of ST-Segment-Elevation Myocardial Infarction.
    Nishiguchi T; Tanaka A; Taruya A; Emori H; Ozaki Y; Orii M; Shiono Y; Shimamura K; Kameyama T; Yamano T; Yamaguchi T; Matsuo Y; Ino Y; Kubo T; Hozumi T; Hayashi Y; Akasaka T
    Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2460-2467. PubMed ID: 27687605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-hospital prognosis and long-term mortality of STEMI in a reperfusion network. "Head to head" analisys: invasive reperfusion vs optimal medical therapy.
    García-García C; Ribas N; Recasens LL; Meroño O; Subirana I; Fernández A; Pérez A; Miranda F; Tizón-Marcos H; Martí-Almor J; Bruguera J; Elosua R
    BMC Cardiovasc Disord; 2017 May; 17(1):139. PubMed ID: 28549452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective, randomized, open-label trial of 6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction: Rationale and design of the "DAPT-STEMI trial".
    Kedhi E; Fabris E; van der Ent M; Kennedy MW; Buszman P; von Birgelen C; Cook S; Wedel H; Zijlstra F
    Am Heart J; 2017 Jun; 188():11-17. PubMed ID: 28577666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of residual platelet reactivity on reperfusion in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Capranzano P; Capodanno D; Bucciarelli-Ducci C; Gargiulo G; Tamburino C; Francaviglia B; Ohno Y; La Manna A; Antonella S; Attizzani GF; Angiolillo DJ; Tamburino C
    Eur Heart J Acute Cardiovasc Care; 2016 Sep; 5(5):475-86. PubMed ID: 26758542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of 30-day mortality and myocardial scar indices for patients treated with prehospital reduced dose fibrinolytic followed by percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myocardial infarction.
    Solhpour A; Chang KW; Arain SA; Balan P; Zhao Y; Loghin C; McCarthy JJ; Vernon Anderson H; Smalling RW
    Catheter Cardiovasc Interv; 2016 Nov; 88(5):709-715. PubMed ID: 27028120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Symptom-Onset-To-Balloon Time, ST-Segment Resolution and In-Hospital Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention in China: From China Acute Myocardial Infarction Registry.
    Song F; Yu M; Yang J; Xu H; Zhao Y; Li W; Wu D; Wang Z; Wang Q; Gao X; Wang Y; Fu R; Sun Y; Gao R; Yang Y;
    Am J Cardiol; 2016 Nov; 118(9):1334-1339. PubMed ID: 27666173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.